Alcon Inc. (ALC)
undefined
undefined%
At close: undefined
84.17
0.04%
After-hours Dec 13, 2024, 04:10 PM EST

Company Description

Alcon Inc., an eye care company, researches, develops, manufactures, distributes, and sells eye care products for eye care professionals and their patients worldwide.

The company's Surgical segment offers equipment, instrumentation and diagnostics, intraocular lenses (IOLs), and other implantables; and consumables, including viscoelastics, surgical solutions, incisional instruments, surgical custom packs, and other products for use in surgical procedures.

Its cataract products include centurion vision system, LenSx femtosecond laser, LuxOR surgical ophthalmic microscope, NGENUITY 3D visualization system, and ORA system for intra-operative measurements; custom pak surgical procedure packs; vitreoretinal products comprising constellation vision systems, procedure packs, lasers and hand-held microsurgical instruments, and grieshaber and MIVS instruments, as well as scissors, forceps and micro-instruments, medical grade vitreous tamponades, and Hypervit vitrectomy probes; refractive surgery products, including WaveLight lasers and Contoura Vision used for LASIK treatment; EX-PRESS glaucoma filtration device; and implantables products, including AcrySof IQ IOLs products include monofocal IOLs and advanced technology IOLs under the PanOptix and ReSTOR brands for the correction of presbyopia and astigmatism at the time of cataract surgery.

Its Vision Care segment provides daily disposable, reusable, and color-enhancing contact lenses; ocular health products, such as dry eye, glaucoma, contact lens care, and ocular allergies; and ocular vitamins and redness relievers under the TOTAL, PRECISION, DAILIES AquaComfort PLUS, Air Optix, Opti-Free, Clear Care, Tears Naturale, Genteal, ICAPS, and Vitalux brands.

The company was formerly known as Alcon Universal S.A. and changed the name to Alcon Inc. in December 2001.

Alcon Inc. was founded in 1945 and is headquartered in Geneva, Switzerland.

Alcon Inc.
Alcon Inc. logo
Country CH
IPO Date Apr 9, 2019
Industry Medical - Instruments & Supplies
Sector Healthcare
Employees 25,000
CEO David J. Endicott

Contact Details

Address:
Chemin de Blandonnet 8
Geneva,
CH
Website https://www.alcon.com

Stock Details

Ticker Symbol ALC
Exchange NYSE
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001167379
CUSIP Number H01301128
ISIN Number CH0432492467
Employer ID 98-0205094
SIC Code 3851

Key Executives

Name Position
David J. Endicott Chief Executive Officer & Director
Ian Bell Senior Vice President & Chief Operating Officer
Timothy C. Stonesifer Senior Vice President & Chief Financial Officer
Arthur B. Cummings M.D. Executive Director
Dr. Franck Leveiller SVice President of Global Research & Development and Chief Scientific Officer
F. Michael Ball Executive Chairman
Kimberly Martin Senior Vice President, Chief HR Officer & Corporate Communications
Margaret Buckley Chief Accounting Officer
Muru Murugappan Senior Vice President and Chief Information & Transformation Officer
Royce R. Bedward J.D. Senior Vice President, General Counsel & Corporate Secretary

Latest SEC Filings

Date Type Title
Nov 12, 2024 6-K Filing
Aug 20, 2024 6-K Filing
Jun 24, 2024 6-K Filing
May 29, 2024 SD Filing
May 13, 2024 6-K Filing
Apr 08, 2024 6-K Filing
Feb 27, 2024 6-K Filing
Feb 27, 2024 20-F Filing
Feb 27, 2024 6-K Filing
Feb 13, 2024 SC 13G Statement of acquisition of beneficial ownership b...